Atea Pharmaceuticals
AVIR
#7829
Rank
โ‚ฌ0.21 B
Marketcap
2,55ย โ‚ฌ
Share price
-3.79%
Change (1 day)
-28.36%
Change (1 year)

EPS for Atea Pharmaceuticals (AVIR)

EPS in 2023 (TTM): -1,19ย โ‚ฌ

According to Atea Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -1,17ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -1,28ย โ‚ฌ a decrease over its 2021 EPS that were of 1,33ย โ‚ฌ.

EPS history for Atea Pharmaceuticals from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-1,19ย โ‚ฌ-6.73%
2022-1,28ย โ‚ฌ-195.89%
20211,33ย โ‚ฌ-645.91%
2020-0,24ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,99ย โ‚ฌ 70.31%๐Ÿ‡บ๐Ÿ‡ธ USA